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RESEARCH
ZnO nanoparticles modulate the ionic 
transport and voltage regulation of lysenin 
nanochannels
Sheenah L. Bryant1,2†, Josh E. Eixenberger1,2†, Steven Rossland1,3, Holly Apsley1,4, Connor Hoffmann1,5, 
Nisha Shrestha1,2, Michael McHugh1, Alex Punnoose1,2 and Daniel Fologea1,2* 
Abstract 
Background: The insufficient understanding of unintended biological impacts from nanomaterials (NMs) represents 
a serious impediment to their use for scientific, technological, and medical applications. While previous studies have 
focused on understanding nanotoxicity effects mostly resulting from cellular internalization, recent work indicates 
that NMs may interfere with transmembrane transport mechanisms, hence enabling contributions to nanotoxicity by 
affecting key biological activities dependent on transmembrane transport. In this line of inquiry, we investigated the 
effects of charged nanoparticles (NPs) on the transport properties of lysenin, a pore-forming toxin that shares funda-
mental features with ion channels such as regulation and high transport rate.
Results: The macroscopic conductance of lysenin channels greatly diminished in the presence of cationic ZnO NPs. 
The inhibitory effects were asymmetrical relative to the direction of the electric field and addition site, suggesting 
electrostatic interactions between ZnO NPs and a binding site. Similar changes in the macroscopic conductance were 
observed when lysenin channels were reconstituted in neutral lipid membranes, implicating protein-NP interactions 
as the major contributor to the reduced transport capabilities. In contrast, no inhibitory effects were observed in the 
presence of anionic  SnO2 NPs. Additionally, we demonstrate that inhibition of ion transport is not due to the dissolu-
tion of ZnO NPs and subsequent interactions of zinc ions with lysenin channels.
Conclusion: We conclude that electrostatic interactions between positively charged ZnO NPs and negative charges 
within the lysenin channels are responsible for the inhibitory effects on the transport of ions. These interactions point 
to a potential mechanism of cytotoxicity, which may not require NP internalization.
Keywords: ZnO, Nanoparticles, Lysenin, Ion transport, Electrophysiology, SnO2, Toxicity, Voltage gated channels, 
Ligand gated channels
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Background
The rapid development of certain nanomaterials (NMs) 
has led to their extensive use in many commercial appli-
cations including cosmetics, sporting goods, automo-
tive parts, and electronics [1–4], while many others are 
under intense investigation for scientific, technological, 
and biomedical applications [5–9]. The large surface area 
to volume ratio of these materials yields novel physical 
and chemical properties that enable applications that are 
unachievable using micron-sized bulk material of iden-
tical composition. The scientific community has spent 
decades developing an understanding of NMs in order to 
control their fundamental physical and chemical prop-
erties. However, early investigations demonstrated that 
some of the same properties that make NMs attractive 
for multiple applications may cause unintended haz-
ardous interactions with biological systems. Therefore, 
environmental and human exposure poses potentially 
significant risks [10], and this paradigm has led to intense 
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investigations on the potential biological impact of NMs 
[11, 12]. While we have thus far attained a tremendous 
body of knowledge on end-point effects such as cytotox-
icity, neurotoxicity, genotoxicity and oxidative stress [13–
16], we lack a thorough understanding of the principles 
by which modulation of size, charge, composition, disso-
lution levels and surface chemistry affect the interaction 
of NMs with living cells.
ZnO nanoparticles (NPs) are considered to be one of 
the more toxic of the metal oxide NMs [17, 18]. Studies 
on ZnO NPs have demonstrated toxicity towards a large 
number of cell lines and model organisms, however, the 
mechanism of cytotoxicity is still under debate. Certain 
physicochemical properties, such as surface chemistry, 
dissolution potential, and their intrinsic ability to pro-
duce reactive oxygen species (ROS) have a strong impact 
on their cytotoxic effects [19–21]. Several studies have 
demonstrated that cytotoxicity stems from high disso-
lution rates, causing elevated levels of  Zn2+ ions in cel-
lular media that eventually disrupt homeostasis and 
leads to cell death [22, 23]. Other groups have suggested 
that their intrinsic ability to produce ROS (which may 
arise from surface defects, such as oxygen vacancies) is 
responsible for the high cytotoxic potential of ZnO NPs 
[24, 25]. In the same line,  SnO2 NPs have been shown to 
inhibit kinetic growth and cytotoxicity towards certain 
cell lines and organisms [18, 26, 27], while other publica-
tions have demonstrated modest to no cytotoxic effects 
[28, 29]. Similar to other NPs, the crystal and hydrody-
namic size of  SnO2 NPs play an important role on their 
toxic effects, and smaller sizes have been shown to cor-
relate with increased toxicity [27].
Our inability to correctly predict how physical and 
chemical properties relate to toxicity stems from the fact 
that biological systems are elaborate and structurally and 
functionally interconnected, making it very difficult to 
isolate distinct interactions responsible for cytotoxicity. 
Therefore, investigations utilizing a simplified model sys-
tem that mimics the structure and function of a biologi-
cal assembly can be an important step towards a more 
complete understanding of mechanisms of nanotoxicity. 
In these regards, we address how the directional flow 
of ions across lipid membranes containing specialized 
transmembrane ion transporters are affected by NPs. 
This work is motivated by the tremendous biological rel-
evance of ionic transport for any living cell, and by the 
evidence that malfunctions of the mechanisms that con-
trol the transmembrane transport may have catastrophic 
consequences for cell functionality [30].
Among transmembrane transporters, voltage-regu-
lated channels play key roles in fundamental cellular pro-
cesses such as creating and maintaining electrochemical 
gradients, transmission of information, ion transport, 
signaling, and metabolism [31]. A salient feature of such 
transporters is the regulation of their activity by trans-
membrane electric fields interacting with voltage-sensing 
domains present in the channel’s structure [32]. The pres-
ence of charged domains in different regions of protein 
channels presents opportunities for electrostatic interac-
tions with charged NPs, which may affect the transmem-
brane transport and functionality of the host cells.
Given the large variety of ion transporters in the cell 
membrane, isolating a particular one in a specific cell 
for relevant studies on transport modulation induced 
by NPs is not an easy task. Moreover, reconstitution of 
a particular ionic transporter in an artificial membrane 
system, although feasible, may require multiple, exten-
sive and costly preparation steps. A simplified system fea-
turing fundamental characteristics of ion channels may 
constitute an excellent model for investigating potential 
nanotoxicity effects originating from the disruption of 
transmembrane transport of ions. Therefore, we propose 
a simplified model that explores the effects of charged 
NPs on the transport of ions through lysenin channels 
inserted into an artificial bilayer lipid membrane (BLM).
Lysenin is a pore-forming protein extracted from the 
coelom of the earthworm E. foetida, which self-assem-
bles as a large conductance nonameric pore (~ 3 nm) in 
artificial and natural lipid membranes containing sphin-
gomyelin (SM) [33–35]. The recently deciphered crystal 
structure indicates large charged domains present within 
the channel [36, 37], thus presenting a strong poten-
tial for electrostatic interactions with charged NPs. The 
physiological role of lysenin is still obscure but the cytol-
ytic and hemolytic activity is indicative of a pore-forming 
toxin [38]. Nonetheless, its relevance for nanotoxicity 
studies stem from several remarkable biophysical proper-
ties it shares with ion channels. Unlike many other pore-
forming toxins and similar to voltage-gated ion channels, 
lysenin channels present asymmetrical voltage-induced 
gating [33, 39]. They adopt an open state at negative 
voltages, while positive voltages larger than ~ +  20  mV 
induce gating and closing [39, 40]. This salient feature is 
complimented by reversible ligand-induced gating, mani-
fested as conformational changes in the presence of low 
concentrations of multivalent metal cations leading to 
channel closure [41, 42]. Once the multivalent cations 
bind and induce conformational changes, the channel 
adopts a sub-conducting or closed state [41, 42]. Another 
advantageous property of lysenin channels is that voltage 
and ligand-gating properties can be easily discriminated. 
This is achieved by reconstituting the channels in neutral 
lipid membranes which maintains the ligand-induced 
gating mechanism but renders lysenin unresponsive to 
the applied voltage [41, 42]. The high transport rate of 
lysenin channels yield large ionic currents which facilitate 
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data recording and analysis. Lastly, lysenin channels are 
easily reconstituted in artificial membrane systems con-
taining SM, are stable for extended time periods, and the 
monomer form of the protein is commercially available.
Methods
Chemicals and nanoparticles
Asolectine (Aso), cholesterol (Chol), SM (from 
Sigma-Aldrich) and diphytanoyl phosphatidylcholine 
(DiPhytPC, from Avanti Polar Lipids) were purchased 
as powders and dissolved in n-decane at a final concen-
tration of 50  mg/mL. For the support electrolyte, NaCl 
(Fisher Scientific) was dissolved in nanopure water at 
a final concentration of 130  mM (if not otherwise indi-
cated) and buffered with 20  mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) at pH  =  7.2. 
ZnO and  SnO2 NPs were synthesized using wet chemi-
cal methods as previously described [43, 44]. Briefly, for 
ZnO NP samples, the precursor zinc acetate dihydrate 
 (Zn[CH3CO2]2·2H2O) was suspended in diethylene gly-
col. The solution was heated and nanopure water was 
added when the solution reached 80 °C. The temperature 
was then brought to and held at 150 °C for 90 min. The 
NPs were collected by centrifugation and subsequently 
washed with ethanol. For  SnO2 NPs, sodium stannate 
 (Na2[Sn(OH)6]) and urea were used as precursors with 
nanopure water as the solvent. The solution was heated 
to 90 °C and held for 90 min. The NPs were collected via 
centrifugation and subsequently washed with nanopure 
water. Characterizations were performed using X-ray 
diffraction (XRD) (Additional file  1: Fig. S1), transmis-
sion electron microscopy (TEM) (Additional file 1: Figs. 
S2, S3), zeta potential (ZP) measurements, dynamic 
light scattering (DLS) (Additional file  1: Fig. S4), X-ray 
photoelectron spectroscopy (XPS) (Additional file  1: 
Fig. S5) and Fourier-transform infrared spectroscopy 
(FTIR) (Additional file  1: Fig. S6). XPS confirmed sam-
ple purity and atomic concentrations for stoichiometric 
ratios. XRD was employed to ensure crystal phase purity 
and to obtain average crystalline size for both samples. 
XRD confirmed the expected hexagonal wurtzite crystal 
structure for ZnO and cassiterite for  SnO2. The average 
crystal size for ZnO and  SnO2 NPs was analyzed with 
Rietveld refinement using Materials Analysis Using Dif-
fraction (MAUD) software and estimated at 8.3 ± 2 and 
4.3 ±  0.04  nm respectively. A JEOL JEM-2100 HR ana-
lytical TEM was used to confirm spherical morphology 
and average crystal sizes. FTIR spectra was collected 
using a Bruker Tensor 247 spectrometer and FTIR pellets 
were produced by first grinding 1.6 mg of each NP sam-
ple with 0.200 g of spectroscopic grade KBr. The ground 
powder mixture was then pressed with 8 tons of pressure 
for 3  min and pellets were analyzed after removing the 
KBr background. Zeta potential and DLS measurements 
were performed, after dispersing the powders in nano-
pure water at a concentration of 1 mg/mL, using a Mal-
vern Zetasizer NanoZS. ZnO NP clusters had an average 
hydrodynamic size (HDS) of 276 nm and average ZP of 
+  32  mV, whereas  SnO2 NP clusters average HDS was 
176 nm with an average ZP of − 42.0 mV.
Bilayer lipid membrane setup
The experimental setup employed the use of a planar 
BLM chamber consisting of two polytetrafluoroethyl-
ene (PTFE) reservoirs separated by a thin (~  120  μm) 
PTFE film that had been pierced with an electric spark 
to create a circular hole of  ~  70  µm diameter [45, 46]. 
The reservoirs were filled with 1  mL buffered electro-
lyte and connected via two Ag/AgCl electrodes inserted 
in the solution to an Axopatch 200B amplifier (molecu-
lar devices). The amplified analog signal fed the DigiData 
1440A digitizer (molecular devices) which provided the 
digital signal for visualization, recording, and further 
analysis. Continuous stirring of the solutions in the BLM 
chamber was assured by a low-noise magnetic stirrer 
(Warner instruments). All the experiments were per-
formed in voltage-clamp mode upon manual or auto-
matic voltage stimulation. The signal recorded during 
various voltage stimulations was further analyzed with 
ClampFit 10.6.2.2 (Molecular Devices) and Origin 8.5.1 
(Origin Lab) software packages.
Experimental procedure
Lipid membrane preparation was performed by “paint-
ing” the hole in the PTFE film with small amounts of 
lipid mixtures composed of 4 mg Aso or DiPhytPC, 2 mg 
Chol, and 2 mg SM dissolved in ~ 400 μL n-decane [46, 
47]. The successful creation of the BLM was indicated by 
measuring the capacitance in response to an applied tri-
angular voltage stimulation, while achievement of a seal 
resistance larger than 1000  GΩ was assessed by meas-
uring the leakage current in response to a DC voltage 
stimulation (100 mV). Channel insertion was performed 
by adding the lysenin monomer (from Sigma-Aldrich, 
0.3 nM final concentration) to the ground (cis) reservoir 
under continuous stirring and at − 60 mV bias potential 
applied to the trans (headstage) reservoir. The application 
of a negative voltage was required to prevent the voltage-
induced gating which manifests at positive transmem-
brane potentials [33, 39, 40]. After the insertion process 
was completed, as indicated by a steady state value of the 
open current, an extensive flushing of the cis reservoir 
with lysenin-free electrolyte was performed to remove 
the bulk monomer and prevent additional insertions. 
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To avoid potential changes in the lysenin functionality 
originating in congestion effects [48], the total number 
of channels inserted into the membranes was limited 
to  ~  1000. To facilitate quantitative comparison of the 
influence of NPs on the transport properties of lysenin 
channels in parallel experiments comprising differ-
ent numbers of inserted channels, we used the relative 
changes in the macroscopic conductance  (Gr  =  G/G0) 
for data plotting, where G is the conductance after addi-
tion of NPs and  G0 is the conductance before addition. In 
order to avoid premature dissolution and/or aggregation, 
the NPs (powder form) were dispersed by sonication for 
5 min in the support electrolyte solution in a sonication 
bath before each addition to the reservoirs.
Results and discussion
Once a steady state current through the population of 
lysenin channels was achieved, the NPs were introduced 
into either side of the chamber with both negative and 
positive voltages applied across the membrane to assess 
their effect on the macroscopic conductance (see Fig.  1 
for a schematic of the setup). The addition of ZnO NPs 
(20  µg/mL final concentration) to either side of the 
membrane containing lysenin channels, when biased by 
− 60 mV, yielded only a modest decrease of the macro-
scopic conductance, i.e. a few percent, irrespective of the 
side of addition (Fig. 2). This slight decrease in the con-
ductance suggests a minimal influence of ZnO NPs on 
the lysenin channels’ ability to transport ions in these 
particular experimental conditions.
To explain the small reduction in conductance, one 
may hypothesize several different mechanisms such as 
ligand gating induced by small amounts of  Zn2+ ions 
provided from low NP dissolution, ligand gating induced 
by NP binding to a specific binding site, or physical 
occlusion by transient NP attachment to the opening of 
the nanopore. Past investigations show a dramatic yet 
reversible decrease of the macroscopic conductance of 
lysenin channels in the presence of low concentrations of 
multivalent cations [41, 42], indicative of strong interac-
tions with lysenin channels. Those interactions have been 
elucidated in single-channel experiments, which provide 
evidence of gating, i.e. transition from the open state 
to a sub-conducting or closed state [41, 42]. To explain 
lysenin’s reversible gating in the presence of multivalent 
cations, it is assumed that the channel’s structure con-
tains at least one negatively-charged binding site with 
high affinity for cations, which triggers gating upon bind-
ing. A potential leakage of  Zn2+ ions from NPs may affect 
the macroscopic conductance of lysenin channels, as 
observed. In addition, if exposed this binding site could 
electrostatically interact with cationic NPs and yield a sig-
nificant decrease in conductance either by induced gating 
or physical occlusion of the conducting pathway. How-
ever, such strong effects were not observed in the above 
experimental conditions, which prompted us to look 
closer to the lysenin’s structure for alternative explana-
tions. The assembled lysenin channel shows the presence 
of multiple anionic domains [36, 37, 49], hence present-
ing opportunities for physical occlusions of the channels 
through electrostatic interactions even in the absence of 
gating. We may account for the weak conductance inhi-
bition by considering the position of a binding site and 
the orientation of the external electric field. A deep-bur-
ied binding site would be inaccessible from either side to 
NPs larger than the channel’s diameter (~ 3 nm), which 
is mostly the case in our investigations. Nanoparticle 
interaction with a binding site present at the trans open-
ing of the channel would be prevented at − 60 mV by the 
electric field orientation. Although the electric field in 
the bulk is very low, its amplitude increases substantially 
when approaching the channel opening (fringe effects), 
therefore keeping the NPs far from a binding site located 
at the cis opening. The same electric field will drive the 
NPs added to the cis side towards the membrane but the 
lack of changes in macroscopic conductance suggest the 
absence of a binding site at this location. The hypothesis 
of an exposed binding site at the trans opening was fur-
ther sustained in similar experiments comprising trans 
NP addition and no transmembrane voltage; in such 
experimental conditions, a marked decrease of the mac-
roscopic conductance was observed at − 60 mV after 2 h 
of NP incubation in the absence of a bias potential (data 
not shown). However, this result could be an artifact 
originating from dissolution during the prolonged NP 
exposure to the electrolyte solution.
To identify if the elusive binding site is located 
either deep within the channel or at the trans side, we 
Fig. 1 The experimental setup comprises lysenin channels reconsti-
tuted into planar lipid bilayer membranes. The modulation of ionic 
transport and regulation by ZnO NPs is assessed in classic voltage-
clamp experiments
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performed the experiments under positive bias potentials 
(Fig.  3). After the channel insertion process, the influ-
ence of ZnO NPs was assessed in experiments compris-
ing of cis or trans addition and opposite orientations of 
the electric field. Lysenin channels are voltage-gated at 
positive voltages greater than ~  +  20  mV but are sta-
ble in the open state for extended time periods as long 
as the applied voltage is less than this critical value [33, 
39]. Interestingly, addition of ZnO NPs to the trans 
side under positive biasing (+ 15 mV to prevent voltage 
gating) induced a rapid and sustained decrease of the 
macroscopic conductance (Fig.  3), while cis addition 
elicited only a weak response in otherwise similar condi-
tions. Consequently, we concluded that the electric field 
plays a major role in preventing ZnO NPs accumulation 
near the membrane when biased by − 60 mV. However, 
in the absence of an electric field or when positive volt-
ages are applied, ZnO NPs may interact with a binding 
site situated at the trans opening of the channel.
Dissolution of ZnO NPs can result in high extracel-
lular  Zn2+ concentrations which have been proposed 
as one of the main mechanisms of ZnO NPs cytotoxic 
effects [22, 23, 50]. Zinc ions inhibit the macroscopic 
conductance of lysenin channels by a ligand-induced 
gating mechanism [41, 42]. Due to the high sensitiv-
ity of lysenin channels to  Zn2+, dissolution may explain 
the observed inhibition of conductance upon exposure 
to ZnO NPs. To eliminate such potential experimental 
artifacts, we performed investigations in similar condi-
tions but added  Zn2+ ions  (ZnSO4; 2 mM final concen-
tration) to the reservoirs instead of ZnO NPs. Addition 
of  Zn2+ to either side, biased by − 60 mV, yielded a sud-
den decrease of the macroscopic conductance in agree-
ment with previous reports (Fig.  4) [41, 42]. Addition 
of the same amount of  Zn2+ to a similar BLM contain-
ing lysenin channels and biased by +  15  mV (to pre-
vent voltage-induced gating) yielded a similar relative 
decrease of the macroscopic open current (Fig.  4). If 
conductance inhibition elicited by ZnO NPs had been 
induced by the  Zn2+ ions dissipating from the NPs, then 
addition to either side would have displayed a similar 
pattern of conductance inhibition. However, addition of 
Fig. 2 ZnO NPs do not alter the ionic conductance of lysenin channels when biased by a − 60 mV transmembrane voltage. Addition of ZnO NPs 
to either trans (a) or cis (b) reservoirs induces only negligible changes of the macroscopic conductance. The experimental values are reported as 
mean ± SD, n = 3. All the data points represent experimental values but some symbols have been removed for improved visibility
Fig. 3 Interactions between lysenin channels and ZnO NPs at 
+ 15 mV bias potential. Cis addition (green) of ZnO NPs yield minor 
changes in the macroscopic conductance. In contrast, trans addition 
(blue) elicits a significant decrease of the macroscopic conductance 
by ~ 70%. The experimental values are reported as mean ± SD, n = 3. 
All the data points represent experimental values but some symbols 
have been removed for improved visibility
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 Zn2+ ions yielded fundamentally different results com-
pared with the experiments involving ZnO NPs.  Zn2+ 
ions affected the macroscopic conductance irrespective 
of the side of addition and direction of the electric field, 
while the inhibitory activity of ZnO NPs depended on 
both these experimental parameters. The total concen-
tration of ZnO NPs was only 20 μg/mL (corresponding 
to ~ 0.25 mM  Zn2+ ions) and resulted in a 70% decrease 
in the macroscopic conductance. In order to obtain an 
approximate decrease of only 45% in conductance meas-
urements with  Zn2+ ions, the experiment employed a 
final concentration of 2.0 mM. Assuming complete dis-
solution of ZnO NPs, this would correlate to approxi-
mately eight times the amount of  Zn2+ ions from  ZnSO4 
in the solution. To further eliminate the possibility that 
the  Zn2+ ions contributed to the observed conductance 
inhibition, experiments with ZnO NPs were carried out 
in the presence of the strong  Zn2+ chelator EDTA. EDTA 
(10 mM) was added to the solutions prior to nanoparti-
cle addition, thus effectively preventing any interactions 
of the free zinc ions from the NPs with lysenin channels. 
These experiments yielded almost identical decreases 
in the macroscopic conductance when compared with 
ZnO NPs with no EDTA (Additional file  1: Fig. S7). 
Our results clearly indicate that the conductance inhi-
bition elicited by ZnO NPs was not a consequence of 
 Zn2+ ions from dissolution. These experiments revealed 
that the extent of the conductance inhibition depended 
on both the orientation of the lysenin channels and the 
electric field relative to the site of ZnO NP addition. The 
observed conductance inhibition may originate from 
local accumulation of NPs by electrophoretic effects, 
specific interactions with the membrane itself, or prefer-
ential interactions with binding sites of lysenin.
Next, we asked whether or not exposure to ZnO NPs 
changes the voltage-induced gating profile. To answer 
this question, the voltage-induced gating of lysenin chan-
nels was assessed from the I–V plot recorded in the range 
−  60 to +  60  mV (Fig.  5) at a voltage rate of 0.2  mV/s 
with and without the addition of ZnO NPs. The macro-
scopic current recorded in absence of NPs (Fig.  5) fea-
tured the well-known characteristics of voltage-induced 
gating, i.e. a linear behavior in the negative voltage range, 
Fig. 4 Zn2+ ions decrease the macroscopic conductance of lysenin channels irrespective of bias potential and site of addition. At + 15 mV 
transmembrane voltage (a),  Zn2+ addition to either the cis or trans reservoir reduces the macroscopic conductance by ~ 40%. Similar decreases are 
recorded upon  Zn2+ interactions with lysenin channels biased by − 60 mV (b). The presented data represents a typical run for each experiment
Fig. 5 Effects of ZnO NPs on lysenin voltage-induced gating. In the 
absence of NPs, lysenin channels begin to close at transmembrane 
potentials greater than 20 mV (green curve). ZnO NPs (20 µg/mL final 
concentration) almost completely abrogate the conductance in the 
positive voltage range (blue curve) and indicate a strong interaction 
with the lysenin channels. All points on the curves are experimental 
data and symbols have been added for discrimination. The presented 
data represents a typical run for each experiment
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indicative of the absence of gating, and a non-linear 
behavior at positive voltages higher than + 20 mV, indic-
ative of channel closure [33, 39, 40]. A typical feature of 
the macroscopic current recorded at positive voltages is 
the transition from high current to low current through a 
dynamic negative resistance region [39, 40]. The macro-
scopic currents recorded in the same voltage range after 
addition of ZnO NPs (20  µg/mL final concentration) to 
the trans side of the membrane yielded a fundamentally 
different I–V plot (Fig. 5). The addition of ZnO NPs elic-
ited a slight decrease in the open current recorded in the 
negative voltage range, however, the I–V characteristic 
preserved quasi-linearity between −  60 and −  20  mV. 
Once the voltage approached neutral values, the mac-
roscopic current greatly deviated from the control I–V 
plot and the ionic transport capabilities of lysenin chan-
nels were strongly diminished in the presence of ZnO 
NPs. Interestingly, the macroscopic conductance started 
to decrease at small negative voltages, as indicated by 
the diminished slope of the I–V plot. This is consistent 
with the hypothesis that the fringe effect of the electric 
field prevents the NPs from interacting with the binding 
site. The magnitude of the electric field decreases with 
decreasing applied voltage and the weak electrophoretic 
force, although opposed, is not sufficient to prevent inter-
actions with the binding site and channel conductance 
modulation. The consistently lower macroscopic cur-
rents indicated that addition of ZnO NPs induced severe 
channel conductance inhibition as demonstrated by the 
large decrease of the macroscopic current at any posi-
tive voltage. At positive voltages, the currents recorded 
in the presence of ZnO NPs were consistently lower than 
the currents recorded in the absence of ZnO NPs up to 
~ + 40 mV, after which the recorded currents were simi-
lar to the control when the channels are in a closed state.
This experiment demonstrated that ZnO NPs affect 
the macroscopic conductance of lysenin channels in a 
voltage-dependent manner but it does not offer a com-
plete mechanistic description. The significant changes 
in the I–V curve after addition of ZnO NPs potentially 
stem from multiple mechanisms. Experimental evidence 
and theoretical modeling have demonstrated that elec-
trostatic interactions between membrane components 
and NPs are key factors that contribute to toxicity and 
the ability of NPs to internalize into cells [51–53]. Our 
experiments comprised a simple system consisting of lys-
enin channels inserted into an artificial BLM composed 
of charged lipids. We assumed that the conductance of 
lysenin channels was affected by interactions between 
the protein channels and NPs but we could not exclude 
interactions between the charged lipids and ZnO NPs as 
a source of conductance modulation. The Aso lipid mix-
ture used for BLM preparation contains several anionic 
components that may interact electrostatically with 
voluminous cationic NPs unable to penetrate the lumen, 
which would lead to channel conductance modulation. 
To elucidate the potential role played by the charged 
lipids, we performed experiments by replacing Aso with 
neutral DiPhytPC. The use of neutral lipids abolishes the 
voltage-induced gating at positive voltages while preserv-
ing the ligand-induced gating observed in the presence 
of multivalent cations [41, 42]. Addition of ZnO NPs to 
the cis side of a neutral membrane containing lysenin 
channels and biased by +  60  mV elicited no change in 
the macroscopic conductance (Fig.  6). However, addi-
tion of ZnO NPs to the trans side of the same membrane, 
biased by an identical positive voltage, yielded a massive 
decrease in conductance similar to the results obtained 
using charged lipids (Fig.  6). The non-symmetrical 
response and preservation of the inhibitory capabilities 
of ZnO NPs recorded for the neutral BLM suggest that 
the inhibition mechanism excludes electrostatic interac-
tions between NPs and lipids. The interaction between 
lysenin channels and ZnO NPs is therefore likely respon-
sible for the observed inhibitory activity.
We have shown that lysenin channels interact with pos-
itively charged ZnO NPs but have not yet demonstrated 
the electrostatic nature of those interactions. Therefore, 
we asked whether or not any NPs electrophoretically 
driven towards a specific or non-specific yet accessible 
binding site would interact with lysenin channels and 
inhibit their conductance. In this respect, we performed 
Fig. 6 Lysenin channels reconstituted in neutral lipid membranes 
interact with ZnO NPs at + 60 mV transmembrane voltage. Cis addi-
tion of ZnO NPs elicits no changes in the macroscopic conductance. 
In contrast, ZnO NPs added to the trans reservoir interact with lysenin 
channels and significantly diminish their ionic transport capabilities. 
The experimental values are reported as mean ± SD, n = 3. All the 
data points represent experimental values but some symbols have 
been removed for improved visibility
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conductance experiments by replacing positively charged 
ZnO NPs with negatively charged  SnO2 NPs (−  42  mV 
ZP). Irrespective of the applied voltage and the addition 
site,  SnO2 NPs did not affect the macroscopic conduct-
ance of lysenin channels (Fig. 7). In order to try to elicit 
interactions with  SnO2 NPs, 200 μg/mL (final concentra-
tion) of  SnO2 NPs were used, which is 10× the concen-
tration of ZnO NPs that induced rapid decreases in the 
macroscopic conductance (Fig. 3). The crystal and hydro-
dynamic sizes of  SnO2 NPs used in this experiment were 
much smaller than ZnO NPs, suggesting that  SnO2 NPs 
would be better suited to inhibit conductance by physi-
cal occlusion. The absolute magnitude of the ZP for  SnO2 
NPs was also larger than ZnO NPs, further strengthen-
ing the hypothesis of a mechanism that requires strong 
electrostatic interactions between cationic ZnO NPs and 
an anionic domain present at the trans side of the lys-
enin channel to induce conductance inhibition. Also, to 
further support the hypothesis that electrostatic interac-
tions between the lysenin channels and ZnO NPs initiate 
a decrease in conductance, we investigated the effects of 
electrostatic screening induced by an increased ion con-
centration in the bulk electrolyte solutions. Addition of 
20 µg/mL ZnO NPs to the trans side of the bilayer con-
taining lysenin channels in 500  mM NaCl and under 
positive bias reduced the conductance by ~  15% (Addi-
tional file  1: Fig. S8), which is much smaller than what 
we observed at 130  mM NaCl concentration (~  70%, 
Fig.  2). In addition, the time required to reach equilib-
rium increased to more than 2500 s, indicating that ionic 
screening weakened the interactions between NPs and 
lysenin channels, and supporting the hypothesis that 
electrostatic interactions are at the origin of the observed 
changes in conductance. However, we may not eliminate 
potential artifacts arising from the effects of screening on 
the ZnO NPs. At high salt concentration, screening may 
accelerate NP aggregation, which is what we observed 
when attempting to further increase the ionic concen-
tration of the bulk electrolyte solutions. The ZnO NPs 
rapidly aggregated into large clusters at the bottom of 
Fig. 7 Interactions between anionic  SnO2 NPs and lysenin channels reconstituted into a planar bilayer lipid membrane. Addition of  SnO2 NPs to the 
trans reservoir at − 60 mV (a) and + 15 mV (b) indicates insignificant changes of the macroscopic conductance. Similarly,  SnO2 NP addition to the 
cis reservoir at − 60 mV (c) and + 15 mV (d) yields negligible changes in the ionic transport capabilities. The presented data represents a typical run 
for each experiment
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the vials in a matter of minutes, which prevented further 
experimentation in high ionic strength conditions.
A few assumptions can be proposed about the mecha-
nism responsible for the observed decrease in macro-
scopic conductance elicited by addition of ZnO NPs. 
Electrostatic interactions may bring ZnO NPs close 
enough to the channels such that the resulting physi-
cal blockage reduces the individual currents. In such 
case, an opposite electric field of appropriate magnitude 
may drive the NPs away from the binding site therefore 
unblocking the channels. Our attempts to apply higher 
voltages across the BLM and to force the unblocking 
were not successful. However, it is possible for the bind-
ing site to have a relatively strong affinity for charged 
ZnO NPs and consequently the force required to remove 
the NPs from the binding sight may require much higher 
electric fields. Unfortunately, such experiments are very 
difficult to achieve as the BLM is prone to disruption at 
high transmembrane voltages.
Another potential inhibition mechanism mimics 
ligand-induced gating. It has been established that lys-
enin channels interact with multivalent cations and 
undergo conformational transitions that force the chan-
nel into closed or sub-conducting states [41, 42]. This 
ligand-induced gating mechanism relies on electrostatic 
interactions between cations and one or more binding 
sites but ionic current blockage stems from the induced 
gating. It is possible that charged ZnO NPs interact elec-
trostatically with one or more binding sites, yet not nec-
essarily the same one(s) involved in the ligand-induced 
gating and would force the channels to adopt a sub-con-
ducting or a closed state. Lastly, defects on the surface of 
ZnO NPs such as oxygen vacancies have been shown to 
correlate with ROS production [24, 54]. Since the electro-
static interactions induce close contact of ZnO NPs with 
the channels, the highly reactive surface of ZnO NPs may 
interact with cysteine and methionine residues in their 
structure which may alter channel functionality and con-
duction similar to reports of oxidation of cysteine resi-
dues in  Ca2+/K+ channels [55, 56].
Conclusions
Our work demonstrates that the transport properties 
of lysenin channels change significantly in the pres-
ence of cationic ZnO NPs. The modulation of the trans-
port properties by NPs is strongly dependent on the net 
charge, and the orientation of the electric field and chan-
nel with respect to the NPs. There is little doubt that the 
primary interaction between NPs and lysenin channels is 
electrostatic. Nonetheless, the simplicity of the experi-
mental system investigated here does not necessarily 
warrant biological interpolation to other protein chan-
nels interacting with NPs, not even ZnO. In complex 
biological environments, the binding of various func-
tional groups on the NP surface may significantly alter 
their ability to interact with membrane components irre-
spective of the surface charge of the pristine nanomate-
rial. Given the aggregation tendency of the investigated 
NPs, we may not exclude aggregation at the membrane 
surface as being at the origin of conductance changes. 
Even the neutral lipids used for our investigations present 
a dipole moment that may initiate NP binding; further 
NP aggregation at these binding sites may impede the 
ionic flow by physical occlusion or by introducing sup-
plementary electrostatic energy barriers for ions. How-
ever, if an induced dipole moment that initiated binding 
of NPs to lipids occurred, then  SnO2 NPs should have 
yielded a similar response due to their higher net charge. 
Nonetheless, dipole–charge interactions have a much 
smaller magnitude than the charge–charge ones, and we 
did not observe such effects when using neutral lipids. 
In spite of these shortcomings, an important conclusion 
of this report pertains to the potential ability of NPs to 
interact with transmembrane transporters without the 
need of internalization. Many previous studies assume 
that cytotoxic effects of NPs are due to translocation of 
NPs into the cytosol by various transport mechanisms 
and/or dissolution of the NPs, disrupting homeostasis 
and interfering with vital cellular processes. Our work 
suggests that NPs may tamper with ionic transport 
mechanisms by basic electrostatic interactions. Given 
the physiological relevance of controlled transmembrane 
transport, such alterations may have catastrophic effects 
for cells. While this observation is generally valid for any 
cell, it may prove extremely helpful for understanding the 
potential neuro-toxic effects of NPs [57]. The physiology 
of the neural cell is based on the transport properties and 
regulation of voltage-gated ion channels, which are trans-
membrane structures with multiple charged domains 
that may interact electrostatically with NPs. Changes in 
the voltage-induced gating mechanism or blockage of 
ionic transport induced by NPs [57] may dramatically 
affect the correct functionality of the nerve cell. Such 
interactions may explain why certain NPs specifically 
alter the individual currents through specific channels 
while the transport properties of other channels are not 
affected by various NPs [58, 59]. The local distribution of 
charge within the structure of several ion channels is cur-
rently known so it may be possible to predict potential 
toxic effects based on interactions with charged NPs, or 
to design NPs intended to alter the activity of transmem-
brane transporters.
This foray into deciphering the effects of NPs on the 
transmembrane transport of ions indicates alterations in 
the transporters’ functionality as a potential mechanism 
of cytotoxicity. A previous study shows that ZnO NPs 
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may induce neuronal cytotoxicity and genotoxicity in the 
absence of internalization or free  Zn2+ ions released from 
the NPs [60]. Future experiments will shed more light on 
intimate mechanistic details and the role that electro-
static interactions play in modulating the biological activ-
ity of protein channels.
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